President of the FDA Statistical Association
Martin Ho, MS, is the President the FDA Statistical Association and he is spearheading the Quantitative Innovation Program at Center for Devices and Radiological Health (CDRH) of the US FDA. Before that, he led a team of statisticians reviewing submissions for neurologic devices at CDRH. Mr. Ho is a voting member of the FDA Research Involved Human Subject Committee, which reviews IRB applications of FDA sponsored clinical studies to protect study participants. He is a member of the CDRH Patient Preferences Initiative and co-organized CDRH’s inaugural Patient Preferences Workshop. He also serves on the Patient-Centered Benefit-Risk Assessment Project Steering Committee of the Medical Device Innovation Consortium, a public private partnership between the FDA and the industry, the patient advocacy groups, CMS, PCORI, and NIH. Mr. Ho participates in developing CDRH’s guidance document to incorporate quantitative patient preference evidence into pre-market approval decisions. Prior to joining the FDA in 2009, Mr. Ho was a senior statistician in various contract research organizations designing, conducting, and analyzing clinical studies for 10 years.